Test Price
2,800 AED✅ Home Collection Available
ADAMTSL2 Gene Geleophysic Dysplasia Type 1 Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
This advanced NGS test analyzes the entire ADAMTSL2 gene with 99.9% diagnostic sensitivity, backed by ISO-certified cold-chain home blood collection across all UAE emirates, direct insurance billing verification via WhatsApp, and expert post-test clinical guidance—delivering a definitive diagnosis of Geleophysic Dysplasia Type 1 within 3–4 weeks.
- 99.9% Diagnostic Sensitivity via ISO Accredited Lab Processing
- VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
- Same-Day Processing with Automated Quality Checks
- Post-Test Telephonic Clinical Guidance on Result Interpretation
- Direct Insurance Billing Verification — WhatsApp +971 54 548 8731
Test Overview & Methodology
The ADAMTSL2 NGS test sequences every coding exon and splice-site region of the ADAMTSL2 gene, detecting pathogenic variants responsible for Geleophysic Dysplasia Type 1—a rare multi-system disorder affecting skin, joints, and cardiac valves. This full-gene analysis provides comprehensive diagnostic confirmation and familial risk assessment.
| Feature | Our ADAMTSL2 NGS Test | Legacy Sanger Sequencing |
|---|---|---|
| Technology | Next‑Generation Sequencing (NGS) | Single‑gene Sanger |
| Coverage | Full gene (all coding regions ±20 bp) | Selected exons only |
| Sensitivity | 99.9% for point mutations & small indels | ~95% (lower CNV detection) |
| Turnaround | 3–4 weeks | 6–8 weeks |
| Clinical Utility | Ideal for diagnostic confirmation & familial screening | Limited to known familial variant |
Physician Insight & Safety Protocols
“As a genetic specialist, I understand the anxiety that genetic testing can bring. This test offers a definitive molecular diagnosis for Geleophysic Dysplasia Type 1, but results must always be correlated with the patient’s complete clinical picture. I strongly advise discussing every finding with a certified genetic counsellor before making any health decisions.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
Safety Exclusion Criteria & Emergency Red Flags
- This test is not valid for prenatal diagnosis without a concurrent amniocentesis/chorionic villus sampling (CVS) procedure; written informed consent from both parents is mandatory for minors in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Inadequate genetic counselling prior to blood draw may delay accurate interpretation; a pre‑test pedigree session is required.
- Emergency Red Flag: Acute chest pain, sudden severe joint swelling, or acute vision changes while awaiting results require immediate emergency evaluation—these may denote cardiac or connective tissue complications unrelated to the test.
- Do not use this test as a sole screening tool in asymptomatic individuals without a relevant family history.
Medication & Clinical Advisory
⚠️ Do not discontinue any prescribed medication or alter your treatment plan without consulting your physician, even if genetic test results are pending or appear suggestive.
Patient FAQ & Clinical Guidance
1. What exactly does the ADAMTSL2 gene test detect, and who should consider it?
This test identifies pathogenic variants in the ADAMTSL2 gene that cause Geleophysic Dysplasia Type 1 and is recommended for individuals with short stature, stiff joints, thickened skin, or a family history of the disorder. Genetic counselling prior to testing is mandatory for accurate interpretation.
2. How should I prepare for the blood draw?
No fasting or medication adjustments are required; however, you must complete a genetic counselling session beforehand to document your family pedigree for accurate interpretation. Our team provides this service before scheduling the blood draw.
3. Is home collection available and covered by my insurance?
Yes, our VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection serves every UAE emirate daily from 8 AM to 11 PM, and direct insurance billing verification via WhatsApp at +971 54 548 8731 confirms coverage before your appointment.
4. What is the turnaround time for results?
Results are typically available within 3–4 weeks from sample receipt, due to the complexity of NGS data analysis and clinical interpretation. You will receive a detailed report via secure digital platform.
UAE Regulatory & Data Privacy Adherence
Your genetic data is handled under strict compliance with:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL)
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields
- Federal Decree-Law No. 4 of 2016 on Medical Liability
All sample processing is conducted in ISO-accredited laboratories within Dubai Healthcare City. Your personal and clinical data remains encrypted and accessible only to authorized healthcare professionals.
Clinical & Logistical Metadata
| Test Name | ADAMTSL2 Gene Geleophysic Dysplasia Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full gene coding regions & splice sites |
| ICD-10-CM Code | Q87.8 |
| LOINC Code | 91854-6 |
| DHA Facility License & Laboratory Address | DHA License #1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE — DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians